Home > Insider Trading > Filing (0001127602-24-016175)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1420910	W Stewart Strong	125 Summer Street Boston MA 02110	President, Global Hospital	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-05-17	284	$95.73	15,324	No	4	F	Direct
Common Stock	Acquisiton	2024-05-17	2,872	$0.00	18,196	No	4	A	Direct
Common Stock	Acquisiton	2024-05-20	2,241	$56.57	20,437	No	4	M	Direct
Common Stock	Disposition	2024-05-20	1,555	$95.08	18,882	No	4	F	Direct
Common Stock	Disposition	2024-05-20	686	$95.11	18,196	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Acquisiton	2024-05-17	6,313	$0.00	6,313	$95.73
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2024-05-20	2,241	$0.00	2,241	$56.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,313		2031-05-17	No	4	A	Direct
2,242	2023-05-18	2028-05-18	No	4	M	Direct

Footnotes

Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
This number includes unvested RSUs previously reported.
The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).
Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.